Buscar
ICON PLC
ICLRAñadir a la lista de seguimiento
163.565USD
-1.965-1.19%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
12.62BCap. mercado
21.91P/E TTM
Más Datos de ICON PLC Compañía
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Información de ICON PLC
Símbolo de cotizaciónICLR
Nombre de la empresaICON PLC
Fecha de salida a bolsaMay 15, 1998
Director ejecutivoBalfe (Barry Edward)
Número de empleados41900
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 15
DirecciónSouth County Business Park
CiudadDUBLIN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIreland
Código postal- -
Teléfono35312912000
Sitio Webhttps://www.iconplc.com/
Símbolo de cotizaciónICLR
Fecha de salida a bolsaMay 15, 1998
Director ejecutivoBalfe (Barry Edward)
Ejecutivos de ICON PLC
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ciaran Murray
Mr. Ciaran Murray
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
20.45K
+2.21%
Mr. Barry Edward Balfe
Mr. Barry Edward Balfe
Chief Executive Officer, Chief Operating Officer
Chief Executive Officer, Chief Operating Officer
4.46K
--
Mr. Nigel Clerkin
Mr. Nigel Clerkin
Chief Financial Officer
Chief Financial Officer
3.85K
--
Dr. John Climax
Dr. John Climax
Independent Director
Independent Director
--
--
Mr. Diarmaid Cunningham
Mr. Diarmaid Cunningham
Chief Administrative Officer, General Counsel, Company Secretary
Chief Administrative Officer, General Counsel, Company Secretary
--
--
Dr. Stephen (Steve) Cutler, Ph.D.
Dr. Stephen (Steve) Cutler, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Eugene Mccague
Mr. Eugene Mccague
Independent Director
Independent Director
--
--
Ms. Julie O'Neill
Ms. Julie O'Neill
Independent Director
Independent Director
--
--
Mr. Ronan Murphy
Mr. Ronan Murphy
Lead Independent Director
Lead Independent Director
--
--
Dr. Linda S. Grais, M.D., J.D.
Dr. Linda S. Grais, M.D., J.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ciaran Murray
Mr. Ciaran Murray
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
20.45K
+2.21%
Mr. Barry Edward Balfe
Mr. Barry Edward Balfe
Chief Executive Officer, Chief Operating Officer
Chief Executive Officer, Chief Operating Officer
4.46K
--
Mr. Nigel Clerkin
Mr. Nigel Clerkin
Chief Financial Officer
Chief Financial Officer
3.85K
--
Dr. John Climax
Dr. John Climax
Independent Director
Independent Director
--
--
Mr. Diarmaid Cunningham
Mr. Diarmaid Cunningham
Chief Administrative Officer, General Counsel, Company Secretary
Chief Administrative Officer, General Counsel, Company Secretary
--
--
Dr. Stephen (Steve) Cutler, Ph.D.
Dr. Stephen (Steve) Cutler, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de ICON PLC?
Los cinco principales accionistas de ICON PLC son: Mr. Ciaran Murray
¿Cuántas instituciones poseen acciones de ICON PLC (ICLR)?
A fecha de 2026Q1, 1395 instituciones poseen acciones de ICON PLC, con un valor de mercado combinado de aproximadamente 83.08M, lo que representa el 108.80% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -15428833.00.